Clinical trial
Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain…
NCT00369785 · Wake Forest University Health Sciences, Other · Completed
Key facts
| NCT number | NCT00369785 |
|---|---|
| Title | Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors |
| Official title | Phase III Double Blind, Placebo Controlled Study of Donepezil in the Irradiated Brain |
| Lead sponsor | Wake Forest University Health Sciences, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Brain Tumors, Metastatic Disease |
| Intervention type | Drug |
| Interventions | donepezil hydrochloride, Placebo |
| Enrollment | 198 |
| Start date | Feb 1, 2008 |
| Primary completion | Jul 1, 2012 |
| Completion | Jul 1, 2012 |
| First posted | Aug 29, 2006 |
| Last update posted | Oct 20, 2021 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: